High sensitive C-reactive protein and interleukin 6 are not related to neointimal hyperplasia in paclitaxel eluting stents or bare metal stents. An intravascular ultrasound study.
Implantation of coronary stents after percutaneous coronary intervention (PCI) may result in an inflammatory response with an increase in high sensitive C-reactive protein (Hs-CRP) and interleukin 6 (IL-6). In 25 patients Hs-CRP and IL-6 increased after coronary artery stenting, however, the increase in the inflammatory response did not differ between PES and BMS stents. The inflammatory response did not predict neointima hyperplasia measured by intravascular ultrasound after 6 months.
Klitkou
Jakob
J
Jensen
Lisette Okkels
LO
Hansen
Henrik Steen
HS
Thayssen
Per
P
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D016503:Drug Delivery Systems; D006801:Humans; D006965:Hyperplasia; D015850:Interleukin-6 / Q000097:blood*; D017239:Paclitaxel / Q000008:administration & dosage*; D015607:Stents; D017539:Tunica Intima / Q000000981:diagnostic imaging / Q000276:immunology / Q000473:pathology; D018084:Ultrasonography, Interventional
D000972:Antineoplastic Agents, Phytogenic; D015415:Biomarkers; D015850:Interleukin-6; D002097:C-Reactive Protein; D017239:Paclitaxel